Menu
Back to Journals » OncoTargets and Therapy » Volume 13
Case report
A Novel ROS1-FBXL17 Fusion Co-Existing with CD74-ROS1 Fusion May Improve Sensitivity to Crizotinib and Prolong Progression-Free Survival of Patients with Lung Adenocarcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,509 | Dovepress* | 4,024+ | 628 | 4,652 | |
| PubMed Central* | 485 | 153 | 638 | ||
| Totals | 4,509 | 781 | 5,290 | ||
| *Since 10 November 2020 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 5 | 0 | 0 | 0 | 1 | 4 |
View citations on PubMed Central and Google Scholar